Clinical Trial Update: Pharmacokinetic Profile of Four Formulations of Fluticasone Furoate (FF) Using Unit Dose Dry Powder Inhaler (UD-DPI) Compared With FF ELLIPTA® Presentation [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing four unit-dose dry powder inhaler formulations of fluticasone furoate with the Ellipta presentation in asthma; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone Furoate (fluticasone furoate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED